[Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia].
D002908:Chronic Disease; D054697:Cytostatic Agents; D006689:Hodgkin Disease / Q000628:therapy*; D007938:Leukemia / Q000628:therapy*; D012507:Sarcoidosis; D014265:Triethylenemelamine / Q000627:therapeutic use*
D054697:Cytostatic Agents; D014265:Triethylenemelamine
HODGKIN'S DISEASE/therapy; LEUKEMIA/therapy; TRIETHYLENE MELAMINE/therapeutic use
Cytostase durch Triäthylenmelamin (TEM) bei Lymphogranulomatose und chronischen Leukämien.